Liposomes in haematology

Bangham, 1964, Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope, Journal of Molecular Biology, 8, 660, 10.1016/S0022-2836(64)80115-7 Bangham, 1965, Diffusion of univalent ions across lamellae of swollen phospholipids, Journal of Molecular Biology, 13, 238, 10.1016/S0022-2836(65)80093-6 Bangham, 1968, Membrane models with phospholipids, Progress in Biophysics and Molecular Biology, 18, 29, 10.1016/0079-6107(68)90019-9 Gregoriadis, 1975, Homing of liposomes to target cells, Biochemical and Biophysical Research Communications, 65, 537, 10.1016/S0006-291X(75)80180-X Weinstein, 1984, Liposomes as drug carriers in Cancer Therapy, Cancer Treatment Reports, 68, 1 Weinstein, 1984, Liposomes as drug carriers in Cancer Therapy, Cancer Treatment Reports, 68, 127 Pozansky, 1984, Biological approaches to the controlled delivery of drugs: a critical review, Pharmacological Reviews, 36, 277 Scherpof, 1984, Interactions of liposomes with plasma proteins, 205 Papahadjopoulos, 1974, Progress in surface science, 141 Scherpof, 1979, The involvement of the lipid phase transition in the plasma-induced dissolution of multilamellar phosphotidylcholine vesicles, Biochimica et Biophysica Acta, 556, 196, 10.1016/0005-2736(79)90042-7 Allen, 1987, Large unilamellar liposomes with low uptake into the reticuloendothelial system, FEBS letters, 223, 42, 10.1016/0014-5793(87)80506-9 Poste, 1984, The challenge of liposome targeting in vivo, vol III Nicolau, 1987, Liposomes as carriers for in vivo gene transfer and expression, Methods in Enzymology, 149, 157, 10.1016/0076-6879(87)49054-X Gregoriadis, 1976, The carrier potential of liposomes in biology and medicine, New England Journal of Medicine, 295, 704, 10.1056/NEJM197609232951305 Gregoriadis, 1976, The carrier potential of liposomes in biology and medicine, New England Journal of Medicine, 295, 708, 10.1056/NEJM197609302951406 Tanaka, 1975, Application of liposomes to the pharmaceutical modification of the distribution characteristics of drugs in the rat, Chemical Pharmacutical Bulletin (Tokyo), 23, 3069, 10.1248/cpb.23.3069 Hoekstra, 1979, Effect of fetal calf serum and serum protein fractions on the uptake of liposomal phosphatidylcholine by rat hepatocytes in primary monolayer culture, Biochimica et Biophysica Acta, 551, 109, 10.1016/0005-2736(79)90357-2 Allen, 1983, Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drugs in rats, Journal of Pharmacology and Experimental Therapeutics, 226, 539 Allen, 1987, Large unilamellar liposomes with low uptake into the reticuloendothelial system, FEBS letters, 223, 42, 10.1016/0014-5793(87)80506-9 Gabizon, 1988, Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumours, 85, 6949 Gabizon, 1983, Enhancement of adriamycin delivery to liver metastatic cells with increased tumoricial effect using liposomes as drug carriers, Cancer Research, 43, 4730 Gabizon, 1982, Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumour activity in mice, Cancer Research, 42, 4734 Olson, 1982, Characterization, toxicity and therapeutic efficacy of adriamycin encapsulated in liposomes, European Journal of Cancer and Clinical Oncology, 18, 167, 10.1016/0277-5379(82)90060-8 Gabizon, 1985, Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumour model, British Journal of Cancer, 51, 681, 10.1038/bjc.1985.103 Underwood, 1972, The ultrastructure and permeability characteristics of the blood vessels of a transplantable rat sarcoma, Journal of Pathology, 107, 157, 10.1002/path.1711070303 Mayhew, 1983, Inhibition of liver metastases of M5076 tumour by liposome entrapped Adriamycin, Cancer Drug Delivery, 1, 43, 10.1089/cdd.1983.1.43 Martin, 1984, Toxicity and therapeutic efficacy of Adriamycin administered as an intravenous infusion or entrapped in liposomes in mice, Proceeds of the American Association of Cancer Research, 25, 267 Mayhew, 1978, Use of liposomes for the enhancement of cytotoxic effects of cytosine arabinoside, Annals of the New York Academy of Sciences, 308, 371, 10.1111/j.1749-6632.1978.tb22035.x Martindale, 1982 Fruhling, 1980, Intracellular peneteration of liposomes containing a water soluble antimitotic drug in L1210 cells, European Journal of Cancer, 16, 1409, 10.1016/0014-2964(80)90049-3 Gregoriadis, 1975, Homing of liposomes to target cells, Biochem Biophys Res Commun, 65, 537, 10.1016/S0006-291X(75)80180-X Heath, 1980, Antibody targeting of liposomes: cell specificity obtained by conjugation of FAb2 to vesicle surface, Science, 210, 539, 10.1126/science.7423203 Urdal, 1980, Tumour-associated Ganglio-N-triosylceramide, Journal of Biological Chemistry, 255, 10509, 10.1016/S0021-9258(19)70492-X Bragman, 1983, Simultaneous interaction of monoclonal antibody-targeted liposomes with two receptors on K562 cells, Biochimica et Biophysics Acta, 730, 187, 10.1016/0005-2736(83)90332-2 Machy, 1982, Differential endocytosis of T and B lymphocyte surface molecules evaluated with antibody-bearing fluorescent liposomes containing methotrexate, 79, 4148 Machy, 1983, Small liposomes are better than large liposomes for specific drug delivery in vitro, Biochem Biophys Acta, 730, 313, 10.1016/0005-2736(83)90348-6 Huang, 1983, Interactions of immunoliposomes with target cells, Journal of Biological Chemistry, 258, 14034, 10.1016/S0021-9258(17)44020-8 Papahadjopoulos, 1978, Annals of the New York Academy of Science, 308, 226, 10.1111/j.1749-6632.1978.tb22025.x Conner, 1986, PH-sensitive immunoliposomes as an efficient and target-specific carrier for antitumor drugs, Cancer Research, 46, 3431 Sculier, 1988, Pilot study of amphotericin B entrapped in sonicated liposomes in cancer patients with fungal infections, European Journal of Cancer and Clinical Oncology, 24, 527, 10.1016/S0277-5379(98)90033-5 Lopez-Berestein, 1985, Liposomal-amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary report, Journal of Infectious Diseases, 4, 704, 10.1093/infdis/151.4.704 Lopez-Berestein, 1987, Treatment of hepatosplenic fungal infections with liposomal-amphotericin, British Journal of Clinical Oncology, 5, 310, 10.1200/JCO.1987.5.2.310 Chopra, 1991 Lopez-Berestein, 1983, Effects of sterols on the therapeutic efficacy of liposomal-amphotericin B in murine candidiasis, Cancer Drug Delivery, 1, 37, 10.1089/cdd.1983.1.37 Hospenthal, 1989, Effect of attachment of anticandidal antibody to the surfaces of liposome encapsulating amphotericin B in the treatment of murine candidiasis, Antimicrobial Agents and Chemotherapy, 33, 16, 10.1128/AAC.33.1.16 Davidson, 1991, Liposomal amphotericin B in drug-resistant visceral leishmaniasis, Lancet, 337, 1061, 10.1016/0140-6736(91)91708-3 Alving, 1980, Liposomes in leishmaniasis: therapeutic effects of antimonial drugs, 8-aminoquinolones and tetracycline, Life Sciences, 26, 2231, 10.1016/0024-3205(80)90207-6 Alving, 1983, Delivery of liposome-encapsulated drugs to macrophages, Pharmacology and Therapeutics, 22, 407, 10.1016/0163-7258(83)90010-4 Coune, 1988, Liposomes as drug delivery system in the treatment of infectious diseases, Infection, 16, 141, 10.1007/BF01644088 1985, 461 Herman, 1983, Prevention of chronic doxorubicin cardiotoxicity in beagles by liposomal encapsulation, Cancer Research, 43, 5427 Sells, 1987, Reduction in toxicity of doxorubicin by liposomal entrapment, Lancet, ii, 624, 10.1016/S0140-6736(87)93011-X Treat, 1990, Antitumor activity of liposome-encapsulated doxorubicin in advanced breast cancer: phase II study, Journal of the National Cancer Institute, 82, 1706, 10.1093/jnci/82.21.1706 Creaven, 1990, Liposomal doxorubicin: clinical trials phase III Gray, 1988, Uptake of antibody-directed cytotoxic liposomes by CD3 on human T-cells, Clinical and Experimental Immunology, 72, 168 Morgan, 1989, Specific targeting and toxicity of sulphonated aluminium phthalocyanine photosensitised liposomes in vitro, British Journal of Cancer, 59, 366, 10.1038/bjc.1989.73 Morgan, 1991 Kirsh, 1987, Liposome-mediated macrophage activities, Methods in Immunology, 149, 147 Fidler, 1982, Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators, Cancer Research, 42, 496 Gregoriadis, 1987, Liposomes as immunological adjuvants antigen incorporation studies, Vaccine, 5, 145, 10.1016/0264-410X(87)90063-6 Alving, 1986, Effectiveness of liposomes as potential carriers of vaccines: applications to cholera toxin and human malaria sporozoite antigen, Vaccine, 4, 166, 10.1016/0264-410X(86)90005-8 Shahun, 1988, Immunopotentiation of the humoral response by liposomes: encapsulation versus covalent linkage, Immunology, 65, 315 Gaber, 1983, Encapsulation of hemoglobin in phospholipid vesicles, FEBS Letters, 153, 285, 10.1016/0014-5793(83)80625-5 Farmer, 1987, Liposome-encapsulated haemoglobin as an artificial oxygen-carrying system, Methods in Enzymology, 149, 184, 10.1016/0076-6879(87)49056-3 Seltzer, 1989, The role of liposomes in diagnostic imaging, Radiology, 171, 19, 10.1148/radiology.171.1.2648470 Williams, 1986, Imaging in rheumatoid arthritis using liposomes labelled with technetium, British Medical Journal, 293, 1143, 10.1136/bmj.293.6555.1143-a Unger, 1989, Hepatic metastases: Liposomal Gd-DPTA-enhanced MR imaging, Radiology, 171, 81, 10.1148/radiology.171.1.2928550 Mukherjee, 1978, Entrapment of metaphase chromosomes into phospholipid vesicles (lipochromosomes): carrier potential in gene transfer, 75, 1361 Mannino, 1968, Liposome mediated gene transfer, Biotechniques, 6, 682 Frahley, 1981, Liposome mediated delivery of deoxyribonucleic acid to cells, Biochemistry, 20, 6978, 10.1021/bi00527a031 Nicolau, 1982, Liposomes-mediated DNA transfer in eukaryotic cells. Dependence of the transfer efficiency on the type of liposomes used and the host cell cycle stage, Biochimica et Biophysica Acta, 721, 185, 10.1016/0167-4889(82)90067-2 Wang, 1987, pH-sensitive immunoliposomes mediated target-cell-specific delivery and controlled expression of a foreign gene ih mouse, 84, 7851 Kaneda, 1989, Increased expression of DNA cointroduced with nuclear protein in adult rat liver, Science, 243, 375, 10.1126/science.2911748 Gray, 1989, Enhanced fluorescence in indirect immunophenotyping by the use of fluorescent liposomes, Journal of Immunological Methods, 121, 1, 10.1016/0022-1759(89)90413-4 Gray, 1990, Immunoliposomes in Haematology Gemke, 1986, ABO and Rhesus phenotyping of fetal erythrocytes in the first trimester of pregnancy, British Journal of Haematology, 64, 689, 10.1111/j.1365-2141.1986.tb02230.x Gray, 1990, Clinical use of fluorescent liposomes for red cell phenotyping Nemerson, 1968, The phospholipid requirement of tissue factor in blood coagulation, Journal of Clinical Investigation, 47, 72, 10.1172/JCI105716 Pitlick, 1970, Binding of the protein component of tissue factor to phospholipids, Biochemistry, 9, 5105, 10.1021/bi00828a010 Mertens, 1984, Binding of human blood-coagulation factors IXa and X to phospholipid membranes, Biochemical Journal, 223, 599, 10.1042/bj2230599 Mertens, 1984, The contributionof Ca2+ and phospholipids to the activation of human blood-coagulation Factor X by activated factor IX, Biochemical Journal, 223, 607, 10.1042/bj2230607 Krishnaswamy, 1988, The binding factor Va to phospholipid vesicles, Journal of British Chemistry, 263, 12 Krishnaswamy, 1988, The binding factor Va to phospholipid vesicles, Journal of British Chemistry, 263, 5714 van de Waart, 1983, Interaction of bovine blood clotting factor Va and its subunits with phospholipid vesicles, Biochemistry, 22, 2427, 10.1021/bi00279a019 Isaacs, 1986, A domain of membrane-bound blood coagulation factor Va is located far from the phospholipid surface. A fluorescence energy transfer measurement, Biochemistry, 25, 4958, 10.1021/bi00365a036 Harris, 1990, Antiphospholipid antibodies, Annotation in British Journal of Haematology, 74, 1, 10.1111/j.1365-2141.1990.tb02530.x Thiagarajan, 1990, Monoclonal immunoglobulin M coagulation inhibitor with phospholipid specificity: mechanism of a lupus anticoagulant, Journal of Clinical Investigation, 66, 397, 10.1172/JCI109869 Pengo, 1987, Immunological specificity and mechanism of action of IgG lupus anticoagulants, Blood, 70, 69, 10.1182/blood.V70.1.69.69 Kelsey, 1984, The diagnosis of lupus anticoagulants by the activated partial thromboplastin time—the central role of phosphatidyl serine, Thrombosis and Haemostasis (Stuttgart), 52, 2 Kelsey, 1984, The diagnosis of lupus anticoagulants by the activated partial thromboplastin time—the central role of phosphatidyl serine, Thrombosis and Haemostasis (Stuttgart), 52, 172, 10.1055/s-0038-1661166 Rauch, 1986, Human hybridomalupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems, Journal of Biological Chemistry, 261, 9672, 10.1016/S0021-9258(18)67567-2 Lupus Anticoagulant Working Party, 1990, Detection of lupus like anticoagulant: current laboratory practice in the United Kingdom, Journal of Clinical Pathology, 43, 73, 10.1136/jcp.43.1.73 Alving, 1985, The Dilute Phospholipid APTT: A sensative assay for verification of lupus anticoagulants, Thrombosis and Haemostasis (Stuttgart), 54, 3 Alving, 1985, The Dilute Phospholipid APTT: A sensative assay for verification of lupus anticoagulants, Thrombosis and Haemostasis (Stuttgart), 54, 709, 10.1055/s-0038-1660103